Emerging Infections (Biomedical Research Reports)

Krause, R. M. (ed.)

ISBN 10: 0124259316 / ISBN 13: 9780124259317

Editore: Academic Press, 2000

Riguardo questo articolo

This is an ex-library book and may have the usual library/used-book markings inside.This book has soft covers. Clean from markings. In good all round condition. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,1000grams, ISBN:9780124259317.

Codice articolo 9927689

Dati bibliografici

• Titolo: Emerging Infections (Biomedical Research Reports)
• Editore: Academic Press
• Data di pubblicazione: 2000
• Lingua: Inglese
• ISBN 10: 0124259316
• ISBN 13: 9780124259317
• Rilegatura: Brossura
• Condizione: Good
• Peso: 1000 grammi
• Cataloghi dei venditori:
  • Medicine

Descrizione articolo

Riassunto

Emerging Infections is a reprint of the inaugural volume of the thematic serial,Biomedical Research Reports Series that provides annual updates on hot topics of interest to a broad spectrum of the biomedical research community. This volume provides state-of-the-art reviews of the most important "new" and reemerging bacterial, viral, and parasitic infections, their life cycles, host defense evasion strategies, and clinical features.Emerging Infections includes in-depth coverage of the history of infectious disease outbreaks, population and evolutionary biology of human pathogens, and current epidemiological models that describe how ecological and demographic changes produce new epidemics. The book covers the major established pathogens as well as the new and sensational--mad cow disease, hantavirus pulmonary syndrome, pathogenicE-coli, and flesh-eating bacteria.

Key Features
* Discusses persisting problems in tuberculosis
* Covers pathogenic escherichia colo 0157:H7
* Explains the revival of Group A Streptococcal diseases
* Provides information on antibiotic resistance in bacteria
* Includes coverage of Korean hemorrhagic fever and hantavirus pulmonary syndrome
* Questions where the Ebola virus comes from and where is it going

Informazioni sull?autore

Dr. John Gallin was appointed to the dual roles of National Institutes of Health (NIH) Associate Director for Clinical Research and inaugural Chief Scientific Officer, the Clinical Center in August 2016. He served as the Director NIH Clinical Center from 1994-2017 after serving 9 years as Scientific Director of the National Institute of Allergy and Infectious Diseases (NIAID) and 12 years as Chief of the Laboratory of Host Defenses. During his tenure as Director of the NIH Clinical Center, Dr. Gallin helped to lead the design, construction, and activation of the Mark O. Hatfield Clinical Research Center, the largest hospital in the world totally dedicated to clinical research. He also oversaw the establishment of a new curriculum for clinical research training, now offered globally reaching over 25,000 students annually in 168 countries, and the development of new information systems for biomedical, translational and clinical research. In 2011, Dr. Gallin accepted, on behalf of the NIH Clinical Center, the Lasker–Bloomberg Public Service Award for its rich history of medical discovery through clinical research. His primary research interests are rare immune disorders of phagocytes, with a focus on chronic granulomatous disease (CGD). His laboratory described the genetic basis for several forms of CGD and other disorders of phagocytes and has done pioneering research that has reduced life-threatening bacterial and fungal infections in patients with these disorders. He has published more than 380 articles in scientific journals and edited two textbooks – Inflammation, Basic Principles and Clinical Correlates (Lippincott, Williams, and Wilkins, 1999, 3rd edition) and Principles and Practice of Clinical Research (Academic Press, 4th edition 2018). He has received numerous awards and honors for his accomplishments and in 2022 received the Weill Cornell Medical College Alumni Award of Distinction, the medical college’s most prestigious alumni award. Dr. Gallin is a member of the American Society for Clinical Investigation, the Association of American Physicians, the National Academy of Medicine of the National Academy of Sciences, a Master of the American College of Physicians, and a Fellow of the Royal College of Physicians-London. He retired from his administrative positions in 2023 and is now an Adjunct Senior Investigator at NIH in the Laboratory of Clinical Immunology and Microbiology in the National Institute of Allergy and Infectious Diseases.